BioInvent (Sweden)

BioInvent (Sweden)

BioInvent International is a Swedish clinical-stage biotech company that discovers and develops novel and first-in-class immunomodulatory antibodies for cancer therapy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioInvent (Sweden), Sweden, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

51%


Total
Publications

134


Total Open
Publications

69


Total
Citations

4.5K


Open Access
Percentage

51%


Total
Publications

134


Total Open
Publications

69


Total
Citations

4.5K

Wikipedia

Website

download

Breakdown

19% 31% 3% 47%

Publisher Open

19%

Both

31%

Other Platform Open

3%

Closed

47%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011121314Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

48%OA Journal

OA Journal 48%

33

Hybrid 21%

14

No Guarantees 31%

21

Other Platform Open

Domain 72%

33

Institution 65%

30

Other Internet 9%

4

Preprint 7%

3

Public 4%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
33
doaj.org OAI-PMH Repository
Institution
23
University of Southampton
Institution
3
University of Cambridge
Institution
3
Figshare
Public
3
DOI
Other Internet
3
Radboud University Nijmegen
Institution
2
bioRxiv
Preprint
2
ZB MED - Information Centre for Life Sciences
Institution
1
Unknown Repository
Other Internet
1
1 / 3

Data updated 12 August 2026

Share

Share

Share